Evidence map›Paper›PMID 25088865›Full record

Observational studyAmerican journal of obstetrics and gynecology2014

Pelvic organ prolapse in a cohort of women treated for stress urinary incontinence.

Peggy Norton, Linda Brubaker, Charles W Nager, Gary E Lemack, Halina M Zyczynski, Larry Sirls, Leslie Rickey, Anne Stoddard, R Edward Varner, Urinary Incontinence Treatment Network

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in American journal of obstetrics and gynecology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 1 country.

Peggy NortonDepartment of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, UT. Electronic address: Peggy.Norton@hsc.utah.edu.
Linda BrubakerDepartment of Obstetrics and Gynecology, Loyola Stritch School of Medicine, Chicago, IL.
Charles W NagerDepartment of Obstetrics and Gynecology, University of California at San Diego School of Medicine, La Jolla, CA.
Gary E LemackDepartment of Urology, University of Texas Southwestern School of Medicine, Dallas, TX.
Halina M ZyczynskiDepartment of Obstetrics and Gynecology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Larry SirlsDepartment of Urology, William Beaumont School of Medicine, Royal Oak, MI.
Leslie RickeyDepartment of Urology, Yale School of Medicine, New Haven, CT.
Anne StoddardNew England Research Institute, Boston, MA.
R Edward VarnerDepartment of Obstetrics and Gynecology, University of Alabama at Birmingham School of Medicine, Birmingham, AL.
Urinary Incontinence Treatment Network
Beaumont Hospital, Royal Oak · USLoyola University Chicago · USNew England Research Institutes · USThe University of Texas Southwestern Medical Center · USUniversity of Alabama at Birmingham · USUniversity of California San Diego · USUniversity of Pittsburgh · USUniversity of Utah · USYale University · US

Funding

Urinary Incontinence Treatment Network: DCCU01DK058229 · NIDDK · NEW ENGLAND RESEARCH INSTITUTES, INC. · PI TENNSTEDT, SHARON L · 2000 to 2012
$16.1M
UAB Continence Treatment Center U01DK060380 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RICHTER, HOLLY E · 2001 to 2009
$3.9M
Urinary Incontinence Treatment NetworkU01DK058225 · NIDDK · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI ZYCZYNSKI, HALINA M · 2000 to 2009
$3.8M
UCSD INCONTINENCE TREATMENT CENTERU01DK060401 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ALBO, MICHAEL · 2001 to 2010
$3.6M
Continuation of the Urinary Incontinence Treatment Network (UITN)U01DK060379 · NIDDK · LOYOLA UNIVERSITY CHICAGO · PI BRUBAKER, LINDA · 2001 to 2009
$3.6M
UTAH URINARY INCONTINENCE TREATMENT NETWORK (UUITN)U01DK060393 · NIDDK · UNIVERSITY OF UTAH · PI NORTON, PEGGY A · 2001 to 2009
$3.4M
Urinary Incontinence Treatment NetworkU01DK058231 · NIDDK · WILLIAM BEAUMONT HOSPITAL RESEARCH INST · PI SIRLS, LARRY T · 2000 to 2009
$3.3M
Urinary Incontinence Treatment Network (UITN)U01DK060397 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI CHAI, TOBY C · 2001 to 2010
$2.7M
Urinary Incontinence Treatment NetworkU01DK060395 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI ZIMMERN, PHILIPPE E · 2001 to 2009
$2.4M
The Urinary Incontinence Treatment NetworkU01DK058234 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI KRAUS, STEPHEN R · 2000 to 2009
$2.3M
NIDDK NIH HHS U01 DK058225NIDDK NIH HHS U01 DK058229NIDDK NIH HHS U01 DK058231NIDDK NIH HHS U01 DK058234NIDDK NIH HHS U01 DK060379NIDDK NIH HHS U01 DK060380NIDDK NIH HHS U01 DK060393NIDDK NIH HHS U01 DK060395NIDDK NIH HHS U01 DK060397NIDDK NIH HHS U01 DK060401NIDDK NIH HHS U01DK58225NIDDK NIH HHS U01DK58229NIDDK NIH HHS U01DK58231NIDDK NIH HHS U01DK58234NIDDK NIH HHS U01DK60379NIDDK NIH HHS U01DK60380NIDDK NIH HHS U01DK60393NIDDK NIH HHS U01DK60395NIDDK NIH HHS U01DK60397NIDDK NIH HHS U01DK60401
6 · The paper itself

Abstract

objectiveThe aim of our study was to observe pelvic organ prolapse (POP) over time, treated and untreated, in a group of highly characterized women being followed up subjectively and objectively over 5-7 years following continence surgery. STUDY

designWe measured baseline prolapse symptoms and anatomic prolapse in subjects enrolled in the trial of midurethral sling (TOMUS) and E-TOMUS, and measured these same parameters annually for 5-7 years after the index surgery. Additional information about subsequent treatment for POP was also recorded.

resultsIn all, 597 women were randomized to 1 of 2 midurethral sling procedures in the TOMUS; concomitant vaginal procedures for POP were allowed at the surgeon's discretion. Stage 2 POP was present at baseline in 291 subjects (49%). Symptoms of POP were reported in 67 (25%). Of the asymptomatic women, 34 of 223 (15%) underwent a concomitant POP repair at the time of index sling surgery. Anatomic progression of prolapse in women with asymptomatic, unoperated stage 2 POP over the next 72 months was infrequent and occurred in only 3 of 189 subjects (2%); none underwent surgery for POP. Most symptomatic women (47/67 [70%]) underwent a concomitant repair for POP at the index sling surgery. Three of the 47 women who had undergone concomitant repair for symptomatic stage 2 POP underwent repeat POP surgery (2 at 36 months and 1 at 48 months.)

conclusionFor patient populations similar to the TOMUS and E-TOMUS populations, surgeons may counsel women with asymptomatic stage 2 POP that their prolapse is unlikely to require surgery in the next 5-7 years.

Indexed as

Suburethral SlingsAsymptomatic DiseasesCohort StudiesCystoceleDisease ProgressionFemaleHumansLongitudinal StudiesPelvic Organ ProlapseSeverity of Illness IndexUrinary Incontinence, StressUterine ProlapseVaginaasymptomatic cystocelemidurethral slingstress urinary incontinenceurogynecology

Identifiers

PMID25088865
PMCPMC4363109
OpenAlexW2048580554

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.